Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
Fujian Zitian Media Technology
300280
SigmaStar Technology
301536
CN Stock MarketDetailed Quotes
000831 China Rare Earth Resources And Technology
- 29.28
- -0.02-0.07%
Not Open Dec 18 15:00 CST
31.07BMarket Cap-321.76P/E (TTM)
29.59High29.17Low123.09KlotVolume29.34Open29.30Pre Close361.36MTurnover1.16%Turnover Ratio74.31P/E (Static)1.06BShares38.8852wk High6.79P/B31.07BFloat Cap20.1852wk Low32.23Limit Up1.06BShs Float59.68Historical High26.37Limit Down1.43%Amplitude0.95Historical Low0.08Dividend TTM29.36Avg Price56.75KlotAsk0.27%Div YieldTTM100Lot Size62.05KlotBid
China Rare Earth Resources And Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -45.03%1.95B | -52.77%1.15B | -81.94%301.56M | -5.40%3.99B | 12.10%3.55B | 11.10%2.45B | 38.26%1.67B | 41.79%4.22B | 58.21%3.17B | 39.82%2.2B |
| Operating revenue | -45.03%1.95B | -52.77%1.15B | -81.94%301.56M | -5.40%3.99B | 12.10%3.55B | 11.10%2.45B | 38.26%1.67B | 41.79%4.22B | 58.21%3.17B | 39.82%2.2B |
| Other operating revenue | ---- | 57.65%4.07M | ---- | 118.91%12.97M | ---- | -12.40%2.58M | ---- | -20.78%5.93M | ---- | -44.40%2.94M |
| Total operating cost | -37.60%1.88B | -45.27%1.11B | -77.17%322.59M | 3.56%3.33B | 13.35%3.02B | 14.01%2.03B | 44.19%1.41B | 18.71%3.21B | 52.94%2.66B | 35.93%1.78B |
| Operating cost | -39.45%1.74B | -48.34%995.94M | -78.78%288.56M | 4.66%3.1B | 11.03%2.87B | 11.71%1.93B | 44.84%1.36B | 13.96%2.96B | 54.69%2.58B | 36.02%1.73B |
| Operating tax surcharges | -22.92%66.62M | 11.45%64.92M | -62.91%12.63M | -11.50%116.59M | 2,191.02%86.42M | 1,982.59%58.25M | 2,007.12%34.05M | 3,061.88%131.74M | 77.81%3.77M | 79.48%2.8M |
| Operating expense | 14.12%2.55M | 38.90%1.8M | 9.63%750.23K | 19.73%3.71M | 20.53%2.23M | 6.34%1.3M | 15.39%684.31K | -41.30%3.1M | -48.70%1.85M | -53.41%1.22M |
| Administration expense | 7.55%54.78M | -0.39%37.91M | 6.26%15.7M | 1.87%83.72M | 14.34%50.94M | 24.78%38.06M | -40.27%14.77M | 54.19%82.19M | 17.52%44.55M | 30.44%30.5M |
| Financial expense | -26.23%-11.16M | -94.96%-9.81M | -196.91%-6.45M | -217.43%-13.86M | -143.61%-8.84M | -130.56%-5.03M | -120.65%-2.17M | -62.56%11.81M | 13.19%20.27M | 85.98%16.47M |
| -Interest expense (Financial expense) | -38.80%2.63M | 89.08%5.78M | -54.79%728.2K | -81.94%5.18M | -81.91%4.3M | -83.30%3.06M | -85.75%1.61M | -30.92%28.67M | 11.75%23.8M | 80.82%18.31M |
| -Interest Income (Financial expense) | -3.77%-13.83M | -89.13%-15.63M | -82.23%-7.2M | -13.70%-19.25M | -273.80%-13.33M | -339.91%-8.26M | -397.39%-3.95M | -68.27%-16.93M | 3.57%-3.57M | -24.39%-1.88M |
| Research and development | 57.11%36.09M | 58.67%23.01M | 98.93%11.4M | 61.77%40M | 84.66%22.97M | 76.05%14.5M | 61.07%5.73M | 60.07%24.73M | 5.81%12.44M | 3.21%8.24M |
| Credit Impairment Loss | 93.06%-439.66K | 98.20%-62.83K | 164.60%1.14M | -177.31%-2.64M | -266.55%-6.34M | -181.48%-3.48M | -324.54%-1.76M | -7.92%3.41M | 142.13%3.81M | 316.67%4.27M |
| Asset Impairment Loss | -175.46%-331.18M | -77.79%-346.15M | -170.22%-346.31M | -2,217.83%-124.31M | -526.61%-120.23M | -1,645.82%-194.7M | -2,261.97%-128.16M | 70.39%-5.36M | 23.39%-19.19M | 79.93%-11.15M |
| Other net revenue | -158.93%-319.17M | -71.76%-335.24M | -164.06%-343.53M | -11,806.92%-112.28M | -553.64%-123.27M | -1,850.79%-195.18M | -1,961.57%-130.09M | 87.85%-943.01K | -3.86%-18.86M | 81.51%-10.01M |
| Invest income | 261.22%1.2M | 169.99%566.56K | 159.34%417.96K | 104.33%198.33K | 85.95%-746.84K | 83.08%-809.46K | 61.63%-704.29K | -345.89%-4.58M | -826.29%-5.32M | -8,499.12%-4.78M |
| -Including: Investment income associates | -58.33%1.17M | -76.07%365.53K | ---- | -1.40%4.35M | 9.39%2.8M | 0.15%1.53M | 98.61%797.28K | -8.60%4.41M | -18.10%2.56M | -24.24%1.53M |
| Asset deal income | 109.71%39.3K | 2.33%-7.11K | 297.76%4.36K | -843.56%-404.3K | -1,067.51%-404.51K | -117.33%-7.28K | -105.25%-2.21K | -97.52%54.37K | -98.07%41.81K | -98.06%42K |
| Other revenue | 151.85%11.2M | 173.09%10.42M | 130.91%1.22M | 169.07%14.88M | 147.44%4.45M | 136.12%3.82M | 318.33%526.88K | 113.10%5.53M | -25.49%1.8M | 34.21%1.62M |
| Operating profit | -161.14%-250.46M | -236.85%-294.19M | -386.89%-364.56M | -45.23%549.01M | -15.73%409.66M | -47.03%214.97M | -42.68%127.07M | 286.47%1B | 100.08%486.16M | 96.31%405.83M |
| Add:Non operating Income | 3,820.66%68.61K | 4,850.76%66.84K | 881.54%13.25K | -32.64%564.13K | -99.87%1.75K | -78.79%1.35K | -75.29%1.35K | 22.95%837.55K | 109.07%1.4M | -99.05%6.36K |
| Less:Non operating expense | 66.97%118.84K | --99.56K | ---- | -85.18%74.63K | 15.14%71.17K | ---- | ---- | -85.82%503.51K | -88.88%61.82K | 1,593.01%433.75 |
| Total profit | -161.16%-250.51M | -236.87%-294.22M | -386.88%-364.55M | -45.20%549.5M | -15.98%409.6M | -47.03%214.97M | -42.68%127.08M | 290.93%1B | 100.54%487.5M | 95.68%405.84M |
| Less:Income tax cost | -162.84%-52.82M | -263.99%-54.35M | -484.58%-73.92M | -46.16%110.07M | -27.41%84.06M | -65.55%33.14M | -63.41%19.22M | 308.51%204.45M | 219.29%115.8M | 207.67%96.21M |
| Net profit | -160.73%-197.68M | -231.93%-239.88M | -369.46%-290.63M | -44.95%439.43M | -12.42%325.54M | -41.27%181.83M | -36.24%107.86M | 286.67%798.31M | 79.71%371.7M | 75.80%309.63M |
| Net profit from continuing operation | -160.73%-197.68M | -231.93%-239.88M | -369.46%-290.63M | -44.95%439.43M | -12.42%325.54M | -41.27%181.83M | -36.24%107.86M | 286.67%798.31M | 79.71%371.7M | 75.80%309.63M |
| Less:Minority Profit | -61.78%5.31M | -54.48%4.54M | -67.41%-1.87M | -26.69%21.76M | 283.20%13.91M | 102.06%9.97M | -203.69%-1.12M | 168.53%29.68M | -59.38%3.63M | -26.53%4.94M |
| Net profit of parent company owners | -165.14%-203M | -242.22%-244.42M | -364.98%-288.76M | -45.66%417.67M | -15.33%311.63M | -43.60%171.85M | -35.17%108.97M | 293.35%768.63M | 85.99%368.07M | 79.85%304.69M |
| Earning per share | ||||||||||
| Basic earning per share | -160.21%-0.1913 | -231.45%-0.2303 | -364.95%-0.2721 | -46.03%0.4229 | -15.33%0.3177 | -43.59%0.1752 | -40.08%0.1027 | 293.37%0.7836 | 85.93%0.3752 | 79.85%0.3106 |
| Diluted earning per share | -160.21%-0.1913 | -231.45%-0.2303 | -364.95%-0.2721 | -46.03%0.4229 | -15.33%0.3177 | -43.59%0.1752 | -40.08%0.1027 | 293.37%0.7836 | 85.93%0.3752 | 79.85%0.3106 |
| Other composite income | -1.35%-3M | -7,500.00%-2.96M | ||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | -1.35%-3M | ---- | ---- | ---- | -7,500.00%-2.96M | ---- | ---- |
| Total composite income | -160.73%-197.68M | -231.93%-239.88M | -369.46%-290.63M | -45.13%436.43M | -12.42%325.54M | -41.27%181.83M | -36.24%107.86M | 285.16%795.34M | 79.71%371.7M | 75.80%309.63M |
| Total composite income of parent company owners | -165.14%-203M | -242.22%-244.42M | -364.98%-288.76M | -45.84%414.67M | -15.33%311.63M | -43.60%171.85M | -35.17%108.97M | 291.75%765.66M | 85.99%368.07M | 79.85%304.69M |
| Total composite income of minority owners | -61.78%5.31M | -54.48%4.54M | -67.41%-1.87M | -26.69%21.76M | 283.20%13.91M | 102.06%9.97M | -203.69%-1.12M | 168.53%29.68M | -59.38%3.63M | -26.53%4.94M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.